GB940189A - Anti-inflammatory and anti-pyretic pharmaceutical composition - Google Patents

Anti-inflammatory and anti-pyretic pharmaceutical composition

Info

Publication number
GB940189A
GB940189A GB1382261A GB1382261A GB940189A GB 940189 A GB940189 A GB 940189A GB 1382261 A GB1382261 A GB 1382261A GB 1382261 A GB1382261 A GB 1382261A GB 940189 A GB940189 A GB 940189A
Authority
GB
United Kingdom
Prior art keywords
methyl
inflammatory
hydroxy
pyretic
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1382261A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERAPIE ENERGETIQUE LAB DE
Original Assignee
THERAPIE ENERGETIQUE LAB DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR832013A external-priority patent/FR19M/en
Priority claimed from FR851130A external-priority patent/FR1098M/en
Application filed by THERAPIE ENERGETIQUE LAB DE filed Critical THERAPIE ENERGETIQUE LAB DE
Publication of GB940189A publication Critical patent/GB940189A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

2-Hydroxy-3-methyl-benzene-1-carboxamide is prepared by reacting 2-hydroxy-3-methyl-benzoir acid with methanol to give methyl 2-hydroxy-3-methyl-benzoate and then reacting this with ammonia. An example is given.ALSO:An anti-inflammatory and anti-pyretic composition comprises promethazine (10-(2-dimemethylaminopropyl) - phenothiazine hydrochloride) and 2-hydroxy-3-methyl-benzene-1-carboxamide. The ratio of promethazine to the carboxamide is preferably 1 to 100 by weight. Capsules and cachets are referred to.
GB1382261A 1960-07-05 1961-04-17 Anti-inflammatory and anti-pyretic pharmaceutical composition Expired GB940189A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR832013A FR19M (en) 1960-07-05 1960-07-05 New anti-inflammatory and antipyretic product.
FR851130A FR1098M (en) 1961-01-30 1961-01-30 New analgesic product.

Publications (1)

Publication Number Publication Date
GB940189A true GB940189A (en) 1963-10-23

Family

ID=26186664

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1382261A Expired GB940189A (en) 1960-07-05 1961-04-17 Anti-inflammatory and anti-pyretic pharmaceutical composition

Country Status (1)

Country Link
GB (1) GB940189A (en)

Similar Documents

Publication Publication Date Title
GB940189A (en) Anti-inflammatory and anti-pyretic pharmaceutical composition
FR1282518A (en) Nu-acylated derivatives of (3.5-diamino-2. 4. 6-tri-iodo-benzoyl) -aminated acids
BE603824A (en) New derivatives of indan-dione-1,3 and methods of preparation thereof
FR1307710A (en) Process for the preparation of beta-hydroxy-alpha-sulfonic acid anhydrides and their derivatives
FR1328303A (en) Process for the preparation of resinous complex of phenyl-2-halo-t-butylamine and its derivatives
FR1304687A (en) Process for the preparation of fluorinated aromatic amino acid and its derivatives
FR1259159A (en) Process for the preparation of arylamino-anthraquinones and resulting dye composition
FR1295349A (en) Process for the preparation of 6-amino-penicillanic acid and its derivatives
BE608669A (en) Preparation of 6-amino-penicillanic acid derivatives
CA601119A (en) Preparation of unsaturated cyclic urea derivatives
FR1259501A (en) Improvements made to the preparation of derivatives of pregnane 9alpha-halo 16 alpha-methylated
FR84030E (en) Process for the preparation of beta-hydroxy-alpha-sulfonic acid anhydrides and their derivatives
FR1241151A (en) Improvements to the amino-guanidine preparation process
FR1259745A (en) 3'-methyl-spyro derivatives
FR78317E (en) Process for the preparation of 16, 17 methylenic steroid derivatives
BE593331A (en) Glycyrrhetinic acid derivatives
BE603206A (en) Process for the preparation of 4-hydroxyfluoranthene and its derivatives
FR1279590A (en) Process for the preparation of hydroxypregnans and their functional derivatives
FI37409A (en) Process for the preparation of 2,6-dimethyl-3-amino-4-alkoxybenzoic acid derivatives
CA600440A (en) Preparation of imidazolinepropionic acid derivatives
FR1458904A (en) Process for the preparation of isocoumarin-carboxylic acids and their derivatives
FR1426862A (en) Process for the preparation of 4-alkyl-17beta-hydroxy-4-androstene-3-ones and their 17-acylated derivatives
AU255326B2 (en) Entitled DISULFIDE COMPOUNDS OF OCTANOIC ACID DERIVATIVES
FR1291529A (en) Process for the preparation of 6-chloro-7-sulfamido-benzodihydro-1, 2, 4-thiadiazine-1, 1 dioxide and its alkyl derivatives
FR1312410A (en) Imidazoline derivatives and their preparation